RO

Roivant Sciences LtdNASDAQ ROIV Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

8.911

Middle

Exchange

XNAS - Nasdaq

View Section: Financials

Roivant Statements

RO

Roivant Income Statement

B

M

USD (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2024-06-30
%

55.132

100

3.978

7.2

51.154

92.8

98.031

177.8

183.7

333.2

281.73

511

-230.57

-418.2

73.954

134.1

116.38

211.1

70.145

127.2

12.655

23

95.297

172.9

0.122

781.63

2024-03-31
%

28.93

100

4.412

15.3

24.518

84.7

120.9

417.9

169.62

586.3

290.52

1004.2

-266

-919.5

92.19

318.7

-33.061

-114.3

-191.45

-661.8

-8.957

-31

-151.12

-522.3

-0.188

802.72

2023-12-31
%

37.14

100

3.668

9.9

33.472

90.1

123.72

333.1

197.28

531.2

321

864.3

-287.53

-774.2

12.042

32.4

25.412

68.4

5 098.34

13727.3

25.672

69.1

5 096.18

13721.6

6.035

844.46

2023-09-30
%

37.1

100

3.27

8.8

33.84

91.2

145.93

393.3

164.36

443

310.28

836.3

-276.45

-745.1

-40.8

-110

-27.46

-74.02

-327.36

-882.4

3.76

10.1

-304.33

-820.3

-0.4

770.23

2023-06-30
%

21.62

100

4.21

19.5

17.41

80.5

137.63

636.6

156.19

722.4

293.83

1359.1

-276.41

-1278.5

0.24

1.1

-49.92

-230.9

-326.09

-1508.3

1.75

8.1

-291.82

-1349.8

-0.38

759.27

2023-03-31
%

27.38

100

4.18

15.3

23.2

84.7

131.86

481.6

125.51

458.4

257.36

940

-234.17

-855.3

38.17

139.4

16.78

61.3

-179.22

-654.6

-3.79

-13.8

-33.62

-122.8

-0.04

757.74

2022-12-31
%

17.05

100

3.59

21.1

13.47

79

223.28

1309.6

168.26

986.9

391.54

2296.4

-378.07

-2217.4

27.75

162.8

-44.27

-259.6

-382.08

-2240.9

2.82

16.5

-352.01

-2064.6

-0.49

713.32

2022-09-30
%

12.53

100

3.64

29.1

8.89

70.9

132

1053.5

157.66

1258.3

289.66

2311.7

-280.76

-2240.7

-57.34

-457.6

7.59

60.6

-313.76

-2504.07

2.17

17.3

-291.59

-2327.1

-0.42

699.89

2022-06-30
%

4.32

100

1.73

40

2.59

60

135.83

3144.2

149.07

3450.7

284.9

6594.9

-282.31

-6535

-25.18

-582.9

-42.3

-979.2

-349.79

-8097

4

92.6

-331.81

-7680.8

-0.48

695.88

2022-03-31
%

9.22

100

0.46

5

8.76

95

136.59

1481.5

138.97

1507.3

275.57

2988.8

-266.8

-2893.7

-74.21

-804.9

44.5

482.6

-291.48

-3161.4

-0.16

-1.7

-270.06

-2929.07

-0.39

692.21

2021-12-31
%

24.34

100

1.38

5.7

22.96

94.3

153.45

630.4

115.53

474.7

268.98

1105.1

-246.02

-1010.8

-39.47

-162.2

-20.55

-84.4

-306.05

-1257.4

0.04

0.2

-284.54

-1169.02

-0.41

686.59

2021-09-30
%

13.99

100

6.38

45.6

7.61

54.4

254.26

1817.4

437.78

3129.2

692.04

4946.7

-684.43

-4892.3

474.54

3392

-15.35

-109.7

-225.24

-1610.007

0.4

2.9

-208.48

-1490.2

-0.32

650.23

2021-06-30
%

7.74

100

0.74

9.6

6.99

90.3

78.63

1015.9

82.75

1069.1

161.38

2085

-154.39

-1994.7

-11.06

-142.9

-2.01

-26

-100.99

-1304.8

0.09

1.2

-82.18

-1061.8

-0.12

684.79

2021-03-31
%

15.15

100

0.48

3.2

14.67

96.8

474.35

3131

81.15

535.6

555.5

3666.7

-540.83

-3569.8

-12.29

-81.1

-10.06

-66.4

-563.18

-3717.4

-0.02

-0.1

-509.56

-3363.4

-0.74

684.79

2020-12-31
%

5.75

100

0.68

11.8

5.07

88.2

202.26

3517.6

61.88

1076.2

264.14

4593.7

-259.07

-4505.6

-18.81

-327.1

2.06

35.8

-275.82

-4796.9

-0.22

-3.8

-261.03

-4539.7

-0.41

629.67

2020-09-30
%

1.32

100

0.72

54.5

0.61

46.2

97.41

7379.5

59.74

4525.8

157.15

11905.3

-156.54

-11859.09

84.27

6384.1

-9.36

-709.09

-52.79

-3999.2

0.71

53.8

-35.4

-2681.8

-0.05

684.79

2020-06-30
%

1.58

100

0.18

11.4

1.4

88.6

58.73

3717.1

57.12

3615.2

115.85

7332.3

-114.46

-7244.3

37.23

2356.3

-16.05

-1015.8

-6.76

-427.8

1.22

77.2

-3.24

-205.06

684.79

View Section: Balance Sheet